The National Medicines Agency (Anamed), dependent on the Public Health Institute (ISP), ruled out that Chile has imported cough and cold syrups that would be linked to the death -according to the World Health Organization (WHO)- of 66 children in The Gambia.
“After reviewing the database of Gicona and Sipro (importation by medical prescription), there are no imports of the products indicated in the note. There were also no health records associated with the manufacturer of the products mentioned in the note, “they pointed out from Anamed to T13.
The WHO issued a product alert for four cough syrups produced by Maiden Pharmaceuticals of India. According to the entity, the drugs “could be related to acute kidney injury and the death of 66 children.”
Laboratory analysis of samples of each of the products confirms contamination with diethylene glycol and ethylene glycol in unacceptable amounts.
The medications are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
India’s health ministry said in a statement released Thursday night that they are testing samples of the drugs. Based on the results, they will decide what action to take.
In turn, they commented that the laboratory only exported these drugs to Gambia, adding that it does not market them in India.
